Effect of selective laser trabeculoplasty and standard medical treatment on day tension curve and intra-ocular pressure

2012 ◽  
Author(s):  
M Nagar
2014 ◽  
Vol 2014 ◽  
pp. 1-3 ◽  
Author(s):  
Ahmet Ozkok ◽  
Nevbahar Tamcelik ◽  
Didar Ucar Comlekoglu ◽  
Guzin Iskeleli

A 64-year-old Caucasian man referred for decreased vision after selective laser trabeculoplasty (SLT). Slit lamp examination revealed diffuse corneal edema. Despite intensive topical treatment including steroids, corneal edema did not resolve; on the contrary, it advanced to bullous keratopathy. Corneal edema after SLT is an exceptionally rare complication and in all of the previous reports edema resolved with medical treatment. To the best of our knowledge, this is the first report presenting persistent corneal edema after SLT.


2018 ◽  
Vol 15 (2S) ◽  
pp. 225-230
Author(s):  
A. D. Chuprov ◽  
V. N. Kanyukov ◽  
O. V. Kadnikova ◽  
A. K. Ekimov

Selective laser trabeculoplasty is a widely spread method of primary open-angle glaucoma treatment. Confirmation of SLT treatment efficacy is associated with economic feasibility and is used for reducing costs for patients.The purposeof this study was comparative analysis of the cost value for patients with POAG, following SLT and having medical treatment without surgery, as well as determining the dynamics of the cost of treatment for patients at all its stages. An analysis of 250 medical charts of POAG patients, who underwent SLT (treatment group) and 50 medical charts of patients with POAG, who were treated conservatively (control group) was carried out, IOP before the surgery was from 20 to 30mm Hg. Selective laser trabeculoplasty was performed using Quantel Medical Optimis with Solutis device according to the standard technology. During the whole treatment course IOP every patient was examined 5 times: 1 day after SLT, 1 month, 3 months, 6 months and 1 year after the surgery (treatment group patients) and at primary visit, 1 month, 3 months, 6 months and 1 year later (patients of the control group). Linear method and cluster analysis were used as mathematical methods; data processing was performed using software STATISTICA 10. The obtained results allow to compare the costs for patients received SLT and treated without surgery, as well as the dynamics of the patient costs at every stage of the treatment, that can be concerned for the further clinical and economical correction of the whole treatment course for POAG patients. 


2020 ◽  
Vol 11 (4) ◽  
pp. 8054-8060
Author(s):  
Bhatt Tarang R ◽  
Golwala Dharmesh K

Glaucoma is a multipart disorder which leads to continuous degeneration of the optic nerve leading to partial or total blindness. Topical medications are the most common form of therapy to patients. All medication used in glaucoma acts either decreasing the production of aqueous humour and/or by enhancing its outflow, which aids in reducing intra ocular pressure. Medications that cause a decline in aqueous humor secretion are beta-blockers, a2 agonists, and carbonic anhydrase inhibitors. While medications that enhances aqueous drainage include Cholinergic agonists, prostaglandin analogues and adrenergic agonists. Amongst all the drugs, latanoprost and its combinations offer the highest reduction in intra-ocular pressure, but its instability at room temperature is a major drawback to patients. All types of alternative therapy are still at an initial stage, and there are various scopes of development, and further clinical studies will provide more insight. And surgical procedures, which are mainly Argon laser trabeculoplasty and Selective laser trabeculoplasty, are currently preferred, which provides effective results for the patients, but it is not very suitable for all the patients, and there are a few post-operative complications. Thus, modern research on the reduction of dose, precise drug delivery and sustained reduction of IOP shall help in improvising the medications of glaucoma and help mankind from this serious vision-threatening disease.


2016 ◽  
Vol 57 (9) ◽  
pp. 1489
Author(s):  
Sungsoon Hwang ◽  
Jong Chul Han ◽  
Chang Won Kee

Sign in / Sign up

Export Citation Format

Share Document